Abstract
Thyroid-stimulating hormone (TSH) levels obtained one month after the cessation of anti-thyroid drug treatment were assessed retrospectively for possible use in predicting outcome in 50 patients with a clinical diagnosis of Graves' disease. Thirty-four patients remained in remission at the end of the follow-up period and 16 patients relapsed. Although a TSH level of < 1.2 mU/1 did not discriminate between the two groups, none of the 24 patients who had TSH levels of > 1.2 mU/1 relapsed during the follow-up period, making early discharge from the thyroid clinic possible for these patients.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Schleusener H., Schwander J., Fischer C., Holle R., Holl G., Badenhoop K., Hensen J., Finke R., Bogner U., Mayr W. R. Prospective multicentre study on the prediction of relapse after antithyroid drug treatment in patients with Graves' disease. Acta Endocrinol (Copenh) 1989 Jun;120(6):689–701. doi: 10.1530/acta.0.1200689. [DOI] [PubMed] [Google Scholar]
- Weetman A. P., Ratanachaiyavong S., Middleton G. W., Love W., John R., Owen G. M., Darke C., Lazarus J. H., Hall R., McGregor A. M. Prediction of outcome in Graves' disease after carbimazole treatment. Q J Med. 1986 Apr;59(228):409–419. [PubMed] [Google Scholar]
- Wilson R., Fraser W. D., McKillop J. H., Thomson J. A. The prognostic value of TSH receptor binding and thyroid stimulating antibodies following antithyroid drug treatment of Graves' disease. Acta Endocrinol (Copenh) 1989 Nov;121(5):666–670. doi: 10.1530/acta.0.1210666. [DOI] [PubMed] [Google Scholar]
- Wilson R., Semple C. G., Reid A. M., Glen A. C., McKillop J. H., Thomson J. A. Can thyroid stimulating hormone levels by TSH (IRMA) predict relapse of thyrotoxicosis following carbimazole treatment? Postgrad Med J. 1987 Sep;63(743):755–756. doi: 10.1136/pgmj.63.743.755. [DOI] [PMC free article] [PubMed] [Google Scholar]